Redmile Group, LLC Lava Therapeutics Nv Transaction History
Redmile Group, LLC
- $822 Million
- Q2 2025
A detailed history of Redmile Group, LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Redmile Group, LLC holds 2,074,372 shares of LVTX stock, worth $3.17 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
2,074,372
Previous 2,074,372
-0.0%
Holding current value
$3.17 Million
Previous $2.63 Million
3.95%
% of portfolio
0.33%
Previous 0.28%
Shares
3 transactions
Others Institutions Holding LVTX
# of Institutions
22Shares Held
4.94MCall Options Held
17.9KPut Options Held
200-
Bml Capital Management, LLC Zionsville, IN1.97MShares$3.02 Million1.97% of portfolio
-
Bruce & Co., Inc. Chicago, IL522KShares$798,4670.29% of portfolio
-
Pathway Financial Advisors LLC103KShares$156,8250.02% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$99,4500.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il51.8KShares$79,2600.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $39.5M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...